Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTI-B7-H7 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/138579
Kind Code:
A1
Abstract:
Disclosed are an anti-B7-H7 antibody or an antigen-binding fragment thereof, a preparation method therefor and the use thereof. The antibody comprises VL and/or VH; the VL comprises CDRs or mutations thereof: LCDR1, LCDR2 and LCDR3 as shown in amino acid sequences of SEQ ID NO: 82, SEQ ID NO: 94-100, and SEQ ID NOs: 111, 112, 114-116, 120 and 121; and the VH comprises CDRs or mutations thereof: HCDR1, HCDR2 and HCDR3 as shown in the amino acid sequence of SEQ ID NO: 7, SEQ ID NO: 34 or 36, and SEQ ID NO: 57-68. The anti-B7-H7 antibody or antigen-binding fragment thereof of the present invention has high affinity and high biological activity for B7-H7, and can effectively block the binding of B7-H7 to a receptor CD28H thereof and the binding of B7-H7 to a receptor KIR3DL3 thereof; furthermore, the anti-B7-H7 antibody or antigen-binding fragment thereof only specifically binds to B7-H7 without cross-reacting with other member proteins of the B7 family, and has good stability; in addition, the anti-B7-H7 antibody or antigen-binding fragment thereof shows strong in-vivo anti-tumor activity.

Inventors:
WU XIAODONG (CN)
WANG YONGQIANG (CN)
LV XIAOCHENG (CN)
CHEN FEI (CN)
LI XUEMEI (CN)
ZHAO JIUQIAO (CN)
RONG YIPING (CN)
Application Number:
PCT/CN2023/072622
Publication Date:
July 27, 2023
Filing Date:
January 17, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HARBOUR BIOMED US INC (US)
International Classes:
C07K16/28; A61K39/395; A61P35/00; C07K16/46; C07K19/00; C12N5/10; C12N15/13; C12N15/63; G01N33/50
Foreign References:
CN106414489A2017-02-15
CN112153977A2020-12-29
CN112930357A2021-06-08
US20160002337A12016-01-07
Attorney, Agent or Firm:
LIU , SHEN & ASSOCIATES (CN)
Download PDF: